TRAVERE THERAPEUTICS, INC. Increase (Decrease) in Due from Related Parties
TRAVERE THERAPEUTICS, INC. (TVTX) reported Increase (Decrease) in Due from Related Parties of $137.55 thousand for the 34-month period ending 2013-12-31, per its 10-K/A filed 2015-07-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDueFromRelatedParties · last filed 2015-07-09
- TRAVERE THERAPEUTICS, INC. increase (decrease) in due from related parties for the quarter ending 2013-03-31 was $0.00.
- TRAVERE THERAPEUTICS, INC. increase (decrease) in due from related parties for the quarter ending 2012-12-31 was $137.55K.
- TRAVERE THERAPEUTICS, INC. increase (decrease) in due from related parties for the quarter ending 2012-03-31 was $0.00.
- TRAVERE THERAPEUTICS, INC. increase (decrease) in due from related parties for fiscal 2012 was $137.55K.
| Period end | Increase (Decrease) in Due from Related Parties 1 month | Increase (Decrease) in Due from Related Parties 3 month | Increase (Decrease) in Due from Related Parties 6 month | Increase (Decrease) in Due from Related Parties 9 month | Increase (Decrease) in Due from Related Parties 12 month | Increase (Decrease) in Due from Related Parties 12 month as first filed | Increase (Decrease) in Due from Related Parties 22 month | Increase (Decrease) in Due from Related Parties 25 month | Increase (Decrease) in Due from Related Parties 28 month | Increase (Decrease) in Due from Related Parties 31 month | Increase (Decrease) in Due from Related Parties 34 month |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2013-12-31 | $137.55K 10-K/A · filed 2015-07-09 | ||||||||||
| 2013-09-30 | $0.00 10-Q · filed 2013-11-13 | $137.55K 10-Q/A · filed 2015-07-09 | |||||||||
| 2013-06-30 | $137.55K 10-Q · filed 2013-09-16 | ||||||||||
| 2013-03-31 | $0.00 10-Q/A · filed 2013-09-16 | $137.55K derived: sum of 2 quarters · filed 2015-07-09 | $137.55K 10-Q/A · filed 2013-09-16 | ||||||||
| 2012-12-31 | $137.55K derived: 10-K/A 12 month − 10-Q 9 month · filed 2015-07-09 | $137.55K 10-K/A · filed 2015-07-09 | -$137.55K 10-K · filed 2013-06-13 | -$137.55K 10-K/A · filed 2013-09-16 | |||||||
| 2012-09-30 | $0.00 10-Q · filed 2013-11-13 | ||||||||||
| 2012-08-31 | $137.55K 10-Q/A · filed 2015-07-09 | ||||||||||
| 2012-03-31 | $0.00 10-Q/A · filed 2013-09-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Veradermics, Inc (MANE) | United States | $4.839B |